Melissa S. A. M. Bevers

Melissa S. A. M. Bevers

Auto-generated profile, based on publicly available information

Melissa S. A. M. Bevers

Department of Internal Medicine, VieCuri Medical Center , Tegelseweg 210, 5912 BL, Venlo

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2022 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
PGPiet Geusens
Piet Geusens
MBMelissa Sam Bevers
Melissa Sam Bevers
BRBert van Rietbergen
Bert van Rietbergen
OMOsvaldo D Messina
Osvaldo D Messina
ELEric Lespessailles
Eric Lespessailles
PBPeter Van Den Berg
Peter Van Den Berg
In a randomized clinical trial in patients initiating glucocorticoid therapy (GC-I) or on long-term therapy (GC-C), denosumab every 6 months increased spine and hip bone mineral density at 12 and 24 months significantly more than daily risedronate. The aim of this study was to evaluate the effects of denosumab compared with risedronate on bone strength and microarchitecture measured by high-resolution peripheral quantitative computed tomography (HR-pQCT) in GC-I and GC-C. A subset of 110 patients had high-resolution peripheral quantitative computed tomography (HR-pQCT) scans of the distal radius and tibia at baseline and at 12 and 24 months. Cortical and trabecular microarchitecture were assessed with standard analyses and failure load (FL) with micro-finite element analysis. At the radius at 24 months, FL remained unchanged with denosumab and significantly decreased with risedronate in GC-I (−4.1%, 95% confidence interval [CI] −6.4, −1.8) and, in GC-C, it significantly increased with denosumab (4.3%, 95% CI 2.1, 6.4) and remained unchanged with risedronate. Consequently, FL was significantly higher with denosumab than with risedronate in GC-I (5.6%, 95% CI 2.4, 8.7, p < 0.001) and in GC-C (4.1%, 95% CI 1.1, 7.2, p = 0.011). We also found significant differences between denosumab and risedronate in percentage changes in cortical and trabecular microarchitectural parameters in GC-I and GC-C. Similar results were found at the tibia. To conclude, this HR-pQCT study shows that denosumab is superior to risedronate in terms of preventing FL loss at the distal radius and tibia in GC-I and in increasing FL at the radius in GC-C, based on significant differences in changes in the cortical and trabecular bone compartments between treatment groups in GC-I and GC-C. These results suggest that denosumab could be a useful therapeutic option in patients initiating GC therapy or on long-term GC therapy and may contribute to treatment decisions in this patient population. © 2022 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).

20 October 2020 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
ADA.M. Daniels
A.M. Daniels
MBM.S.A.M. Bevers
M.S.A.M. Bevers
SSS. Sassen
S. Sassen
CWCaroline E. Wyers
Caroline E. Wyers
BRBert van Rietbergen
Bert van Rietbergen
HJH.M.J. Janzing
H.M.J. Janzing
Background: Computed tomography (CT), magnetic resonance imaging, and bone scintigraphy are second-line imaging techniques that are frequently used for the evaluation of patients with a clinically suspected scaphoid fracture. However, as a result of varying diagnostic performance results, no true reference standard exists for scaphoid fracture diagnosis. We hypothesized that the use of high-resolution peripheral quantitative CT (HR-pQCT) in patients with a clinically suspected scaphoid fracture could improve scaphoid fracture detection compared with conventional CT in the clinical setting. Methods: The present study included 91 consecutive patients (≥18 years of age) who presented to the emergency department with a clinically suspected scaphoid fracture between December 2017 and October 2018. All patients were clinically reassessed within 14 days after first presentation, followed by CT and HR-pQCT. If a scaphoid fracture was present, the fracture type was determined according to the Herbert classification system and correlation between CT and HR-pQCT was estimated with use of the Kendall W statistic or coefficient of concordance (W) (the closer to 1, the higher the correlation). Results: The cohort included 45 men and 46 women with a median age of 52 years (interquartile range, 29 to 67 years). HR-pQCT revealed a scaphoid fracture in 24 patients (26%), whereas CT revealed a scaphoid fracture in 15 patients (16%). Patients with a scaphoid fracture were younger and more often male. The correlation between CT and HR-pQCT was high for scaphoid fracture type according to the Herbert classification system (W = 0.793; 95% confidence interval [CI], 0.57 to 0.91; p < 0.001) and very high for scaphoid fracture location (W = 0.955; 95%, CI 0.90 to 0.98; p < 0.001). Conclusions: In the present study, the number of patients diagnosed with a scaphoid fracture was 60% higher when using HR-pQCT as compared with CT. These findings imply that a substantial proportion of fractures—in this study, more than one-third—will be missed by the current application of CT scanning in patients with a clinically suspected scaphoid fracture. Level of Evidence: Diagnostic Level II. See Instructions for Authors for a complete description of levels of evidence.

10 February 2023 in Calcified Tissue International
Verified
Journal Article
Open access
PDF file
STSanne Treurniet
Sanne Treurniet
MBMelissa S. A. M. Bevers
Melissa S. A. M. Bevers
CWCaroline E. Wyers
Caroline E. Wyers
DMDimitra Micha
Dimitra Micha
BTBernd P. Teunissen
Bernd P. Teunissen
EEE Marelise W Eekhoff
E Marelise W Eekhoff
Pregnancy- and lactation-associated osteoporosis (PLO) is a rare form of osteoporosis, of which the pathogenesis and best treatment options are unclear. In this report, we describe the case of a 34-year old woman diagnosed with severe osteoporosis and multiple vertebral fractures after her first pregnancy, who was subsequently treated with teriparatide (TPTD) and zoledronic acid (ZA). We describe the clinical features, imaging examination, and genetic analysis. Substantial improvements were observed in areal and volumetric bone mineral density (BMD), microarchitecture, and strength between 7 and 40 months postpartum as assessed by dual-energy X-ray absorptiometry at the total hip and spine and by high-resolution peripheral quantitative CT at the distal radius and tibiae. At the hip, spine, and distal radius, these improvements were mainly enabled by treatment with TPTD and ZA, while at the distal tibiae, physiological recovery and postpartum physiotherapy due to leg pain after stumbling may have played a major role. Additionally, the findings show that, despite the improvements, BMD, microarchitecture, and strength remained severely impaired in comparison with healthy age- and gender-matched controls at 40 months postpartum. Genetic analysis showed no monogenic cause for osteoporosis, and it is suggested that PLO in this woman could have a polygenic origin with possible susceptibility based on familiar occurrence of osteoporosis.

3 January 2026 in European Journal of Radiology
Verified
Journal Article
Open access
MBMelissa S.A.M. Bevers
Melissa S.A.M. Bevers
SSSofia Spinthaki
Sofia Spinthaki
JKJoeri Kok
Joeri Kok
JBJoop P. van Den Bergh
Joop P. van Den Bergh
EOEdwin H.G. Oei
Edwin H.G. Oei
RBRonald Booij
Ronald Booij
To compare trabecular microarchitecture measurements at the distal radius and tibia from photon-counting detector CT (PCD-CT) at varying radiation doses with high-resolution peripheral quantitative CT (HR-pQCT). Two intact wrist and two intact ankle specimens from an 88-year-old man were scanned with PCD-CT at radiation doses of 2.5, 5, 10, and 20 mGy and with HR-pQCT. Additionally, clinical in-vivo HR-pQCT and PCD-CT scans at the radius and tibia were acquired of a 40-year-old woman with osteoporosis. After bone segmentation, the segmented PCD-CT and HR-pQCT scans were three-dimensionally registered. Cubic volumes (edge length: ex-vivo 6 mm, in-vivo 5 mm) were defined at corresponding locations in the PCD-CT and HR-pQCT scans based on the three-dimensional registration. For each cube, trabecular volume fraction (Tb.BV/TV), thickness (Tb.Th), number (Tb.N), separation (Tb.Sp), and heterogeneity (Tb.1/N.SD) were quantified and compared between corresponding PCD-CT and HR-pQCT cubes. Ex-vivo, linear correlation coefficients (R2) between PCD-CT and HR-pQCT were 0.85-0.97 at 2.5 mGy and remained stable with increasing radiation dose for all parameters except Tb.1/N.SD. For Tb.1/N.SD, R2 increased between 2.5 and 5 mGy and remained stable at higher doses. At each radiation dose, Tb.BV/TV, Tb.N, and Tb.Th values were higher and Tb.Sp and Tb.1/N.SD lower on PCD-CT than on HR-pQCT. In-vivo, R2 was 0.89-0.95 (radius) and 0.82-0.97 (tibia). PCD-CT strongly correlated with HR-pQCT in trabecular microarchitecture measurements at the distal radius and tibia at low, clinically acceptable, radiation dose. Between-modality differences in microarchitecture values are likely related to chosen image analysis settings.

20 February 2026 in JBMR Plus
Verified
Journal Article
Open access
PDF file
SBSerena Bonaretti
Serena Bonaretti
MBMojtaba Barzegari
Mojtaba Barzegari
MBMelissa Bevers
Melissa Bevers
SBSteven Kyle Boyd
Steven Kyle Boyd
ABAndrew J Burghardt
Andrew J Burghardt
DZDženan Zukić
Dženan Zukić
The Open and Reproducible Musculoskeletal Imaging Research (ORMIR) community is a scientific community dedicated to promoting openness and reproducibility in musculoskeletal imaging, image processing, and computational modelling. In this perspective paper, we outline the motivations for conducting transparent research and provide practical guidelines to implement it. We start with defining open and reproducible research and describing the benefits and challenges of working transparently. Next, we redefine the outputs of a computational research study as—ideally—a combination of data, code, and a publication, recommend a folder and file structure that reflects these three study outcomes, and describe how to maintain and update such a structure during the study and at study publication. Finally, we emphasize that working in an open and reproducible manner is a learning process and the best way to acquire the necessary competencies is simply to start. Lay summary: The ORMIR community promotes openness and reproducibility in musculoskeletal imaging research. In this perspective paper, we explain why transparency matters and recommend how to conduct a computational study in an open and reproducible manner focusing on its three outputs: data, code, and publication. Finally, we highlight that the best way to learn these practices is simply to start.

9 March 2026 in Journal of Bone and Mineral Research
Verified
Journal Article
Closed access
ZZZografia Zervou
Zografia Zervou
MBMelissa S A M Bevers
Melissa S A M Bevers
CWCaroline E Wyers
Caroline E Wyers
HBHennie T Bruggenwirth
Hennie T Bruggenwirth
SDSerwet Demirdas
Serwet Demirdas
MZM. Carola Zillikens
M. Carola Zillikens